REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric ... - MarketWatch (press release)

REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric ... MarketWatch (press release) REMICADE® has demonstrated broad clinical utility with indications in Crohn's disease, rheumatoid arthritis (RA), ankylosing spondylitis, psoriatic arthritis, ulcerative colitis (UC), pediatric Crohn's disease, psoriasis, and pediatric UC. ... and more »

Evaluating salivary gland tumors and diseases - Clinical Advisor

Clinical Advisor

Evaluating salivary gland tumors and diseases Clinical Advisor Mumps typically causes bilateral inflammation of the parotid glands (parotitis), but it can occur unilaterally. Fever, headache, painful testicular swelling (orchitis) and a rash may occur as well. The symptoms are generally not severe in children. ...

Novartis Study Shows Ilaris Helps Children With Rare Childhood Arthritis - RTT News

ThirdAge

Novartis Study Shows Ilaris Helps Children With Rare Childhood Arthritis RTT News SJIA is a rare and serious childhood auto-inflammatory disease that affects one child in 100 thousand, and is characterized by skin rash, daily spiking fever, swelling and joint pain. The phase III study of ACZ885 was conducted on 84 patients with ... Novartis study showed ACZ885 provided substantial symptom relief in 84% of ...Reuters (press release) Novartis' canakinumab shows promise in SJIAPharma Times Juvenile Idiopathic Arthritis Potential Treatment Announced by NovartisThirdAge The Pharma Letter (subscription) -SunHerald.com (press release) all 52 news articles »

Report Finds DMARDs Effective in Treating Juvenile Arthritis - MarketWatch (press release)

Report Finds DMARDs Effective in Treating Juvenile Arthritis MarketWatch (press release) Juvenile idiopathic arthritis, sometimes called juvenile rheumatoid arthritis, is a common childhood disease that affects up to 400 out of every 100000 children in the United States. Juvenile idiopathic (meaning it has no known cause) arthritis is the ... and more »